Search
for
Sort by
Research 391–420 of 1000+
- 5% Minoxidil topical foam for men: Hair growth in millennials – a post hoc analysis
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- Systematic review of the evidence for medical skin needling in aesthetic practice
- Abstracts from the 17th Congress of the European Society for Dermatology and Psychiatry
- What is it about your skin cancer that bothers you the most? 700 patients respond
- A New Classification of Male Pattern Baldness and a Clinical Study of the Anterior Hairline
- SUMMARIES OF PAPERS
- Loose anagen hair syndrome: An unusual cause of alopecia in a child
- Profile of alopecia areata in 655 Chinese patients
- Treatment of Hair Loss
- Topical Treatments for Scalp Psoriasis
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery
- Efficacy and Tolerability of a Shampoo Containing Broad-Spectrum Cannabidiol in the Treatment of Scalp Inflammation in Patients with Mild to Moderate Scalp Psoriasis or Seborrheic Dermatitis
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study.
- Role of Hair Prostheses (Wigs) in Patients with Severe Alopecia Areata
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
- The Use of Trichoscopy to Assess the Efficacy of Topical Minoxidil 2% Solution in Patients with Female Pattern Hair Loss
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- COVID-19 and hypopituitarism
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Repetitive Transcranial Magnetic Stimulation for Treatment of Trichotillomania: Case Series
- 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials
- Abstracts
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Oral Baricitinib Restores Hair Loss in Alopecia Areata